|
Match
|
Document |
Document Title |
|
|
7588759 |
Compositions comprising sclareol or derivatives thereof and uses thereof
The present invention provides a composition which includes a sclareol or a derivative thereof, wherein the sclareol or a derivative thereof is bound by a glycoprotein matrix. The composition of...
|
|
|
7211562 |
Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors
The administration of cytotoxic agents followed by the administration of heat shock protein 90 inhibitors, such as ansamycins, has a synergistic effect on the growth inhibition of cells. This...
|
|
|
7166270 |
Methods of screening compounds useful for prevention of infection or pathogenicity
Screening procedures are disclosed for identifying compounds useful for inhibiting infection or pathogenicity. Methods are also disclosed for identifying pathogenic virulence factors.
|
|
|
7029704 |
Anti-itch solution
The anti-itch solution is a solution of hydrogen peroxide, sodium bicarbonate and apple cider vinegar applied to feet to prevent a common fungal infection of feet known as “athlete's foot”.
|
|
|
6861053 |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
Disclosed is a method of diagnosing irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, attention deficit/hyperactivity disorder, autoimmune diseases, such as multiple...
|
|
|
6827953 |
Compositions comprising saccharomyces cerevisiae and lactic acid bacteria
The present invention provides a composition comprising an untreated or treated culture of a mixed microorganism and a functional food comprising said composition. A composition comprising an...
|
|
|
6726908 |
Pharmaceutical formulation
This invention relates to pharmaceutical formulations comprising amoxycillin and a salt clavulanic acid in a ratio of 14:1.
|
|
|
6635260 |
Methods and compositions for prevention and treatment of Clostridium difficile-associated diseases
This invention provides methods and compositions for preventing and treating Clostridium difficile -associated disease in a subject, wherein the subject is either a human or non-human animal. The...
|
|
|
6558618 |
Anti-infection formulation and delivery method
A method of dispersing, in water vapor, an anti-infective therapeutic composition ( 10 ) into the air in a room ( 36 ), in order to treat or prevent transmission of upper respiratory infections,...
|
|
|
6511972 |
Pharmaceutical suspension formulation comprising amoxycillin clavulanic acid and cellulose
A liquid aqueous pharmaceutical suspension formulation containing as amoxycillin trihydrate, potassium clavulanate and microcrystalline cellulose filler is provided.
|
|
|
6472383 |
Pharmaceutical formulations
A pharmaceutical formulation comprises, in combination with a penem of formula (I): in which: R 1 is hydrogen or an organic substituent group; R 2 is a fused bicyclic heterocyclic ring system...
|
|
|
6461627 |
Skin preparations for external use
Skin preparations for external use and cosmetics which contain a fermented soybean extract prepared by extracting with an organic solvent a fermentation product obtained by treating a soybean...
|
|
|
6436398 |
2 β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitors
Compound of formula I: wherein R 1 , R 2 , R 3 , R 4 and n have any of the values defined in the specification, and their pharmaceutically acceptable salts, are useful for inhibiting...
|
|
|
6369050 |
Antibacterial agents
The invention provides an antimicrobial agent capable of producing an excellent effect in the prevention or treatment of bacteria of two or more genera selected from among Streptococcus, Moraxella,...
|
|
|
6328989 |
Use of bicozamycin for the manufacture of a medicament for treating infections with enterohemorrhagic e. coli
The present invention relates to the use of bicozamycins for the prophylaxis and treatment of infections with a verotoxin-producing E. coli, as well as for eradicating verotoxin-producing E. coli...
|
|
|
6281191 |
Compositions and methods for treating hepatitis-C
New compositions and methods for treating patients suffering from hepatitis-C, AIDS, aberrant apoptosis which include N-acetyl-D-glucosaminyl(β-1-4)-N-Acetyl-muramyl-L-ananyl-D-
isoglutami ne...
|
|
|
6277829 |
Process for preparing of aqueous formulation for opthalmic use
The present invention describes a process for the preparation of aqueous formulations containing azithromycin for ophthalmic use, as well any formulations obtained by this process and their topical...
|
|
|
6277374 |
Process for producing by culturing Lactobacillus casei var. rhamnosus yeast and mold inhibiting products
A method for producing a novel yeast and mold inhibiting products (FIC) from a Lactobacillus, particularly a Lactobacillus casei having the yeast and mold producing characteristics of Lactobacillus...
|
|
|
6140306 |
Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (BPI) protein product and antibiotic
The present invention relates to methods and compositions for treating gram-negative bacterial infections, using BPI protein products. Co-treatment, or concurrent administration, of BPI protein...
|
|
|
6054431 |
Anti-gram-positive bacterial methods and materials
The present invention relates to methods of treating gram-positive bacterial infections by administration of a BPI protein product alone, or in combination with an antibiotic. BPI protein product...
|
|
|
6015808 |
Synthesis of pharmaceutical compositions with lactams and β-lactams/oxo thia azabicyclo compounds
Pharmaceutical compositions with heretofore unknown and enhanced physical, chemical, and biological properties are prepared by combining known biologically active parent compounds with oxo thia...
|
|
|
5998182 |
Deterioration inhibitor for emulsion-type processing oil and method for inhibiting deterioration of emulsion-type processing oil using the same
Disclosed are a deterioration inhibitor for an emulsion-type processing oil comprising, as an active ingredient, a culture of a bacterial species selected from the group consisting of Aerococcus...
|
|
|
5981234 |
Use of antibiotics 10381b to promote growth
Antibiotic 10381a 1 , wherein R is hydrogen, is a cytosine-containing antibiotic producible by culturing the novel microorganism Streptomyces arginensis in an aqueous medium and isolation thereof....
|
|
|
5911985 |
Pharmaceutical formulations containing a β-lactamase inhibiting penem in combination with β-lactam antibiotic and their use in the treatment of bacterial infections
A pharmaceutical formulation comprises, in combination with a penem of formula (I), in which: R 1 is hydrogen or an organic substituent group; R 2 is a fused bicyclic heterocyclic ring system of...
|
|
|
5716594 |
Biotin compounds for targetting tumors and sites of infection
Novel biotin amide analogs that are useful for targeting therapeutic and imaging agents to sites of infection and tumors in vivo are disclosed.
|
|
|
5681563 |
7-vinylidene cephalosporins and methods of using the same
Cephalosporins with an exocyclic allene in the 7-position and their pharmaceutically active salts are potent inhibitors of β-lactamases and are therefore useful in the treatment of penicillin...
|
|
|
5679789 |
Pharmaceutical compositions comprising potassium clavulanate and methods of using them
Potassium clavulanate exists in a novel crystalline habit, namely in the form of rosettes, having improved processing properties. The novel form may, for example, be obtained by crystallization or...
|
|
|
5523288 |
Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (BPI) protein product and antibiotic
The present invention relates to methods and compositions for treating gram-negative bacterial infections, using BPI protein products. Co-treatment, or concurrent administration, of BPI protein...
|
|
|
5514664 |
1,4-dihydropyridines for application in combatting resistance to drugs
Optically pure diaryl compounds of formula (I), in which the substituents and symbols have the meanings indicated in the description are proposed as active ingredients in medicinal preparations for...
|
|
|
5494666 |
β-lactam compounds
Compounds of the formula ##STR1## where Z, A, and R are as disclosed herein and pharmaceutically compatible, readily hydrolyzable esters and salts of these compounds are disclosed. The compounds...
|
|
|
5464616 |
6β-substituted penicillanic acids as beta-lactamase inhibitors
A 6β-substituted penicillanic acid of the formula XII: ##STR1## or a pharmaceutically acceptable salt or ester thereof, wherein A and B are each hydrogen wherein the carbon atoms to which A and...
|
|
|
5340579 |
Method of treating dermatological conditions
A method is provided for treating dermatological conditions by binding and blocking 5-a-dihydrotestosterone receptors comprising applying to the skin an effective amount of composition comprising: ...
|
|
|
5314690 |
Method and composition for treating IgE-mediated allergies
The present invention relates to a method and preparations for reducing IgE antibodies to allergens in allergic subjects wherein substance P and an allergen or fragments of allergens or haptens...
|
|
|
5275816 |
Cephalosporin derivatives
7 α-formamido cephalosporin derivatives having a 3[N-(optionally substituted)aminothiopyridinium thiomethyl] substituent have anti-bacterial activity and are of use in anti-bacterial therapy....
|
|
|
5258373 |
Anticoccidial compositions
Compositions comprising a mixture of the antibiotic frenolicin B with a potentiated sulfonamide anticoccidial agent, useful for the treatment and prevention of coccidiosis in animals and methods of...
|
|
|
5124150 |
Process for preparing antiviral antibiotic BU-3889V
Production of an antiviral antibiotic complex, BU-3889V and its bioactive components A 1 , A 2 , A 3 , D 1 , D 2 and D 3 , by fermentation of a BU-3889V producing strain of the new microorganism...
|
|
|
5108747 |
Stable oxpenem-3-carboxylic acids as beta-lactamase inhibitors
A pharmaceutical preparation comprising an antibiotic, a pharmaceutical excipient therefor, and in addition an oxapenem-3-carboxylic acid of the formula ##STR1## or a pharmaceutically acceptable...
|
|
|
5064821 |
Method and compositions for overcoming tetracycline resistance within living cells
The present invention provides an improved methodology by which therapeutically to overcome resistance to tetracycline in living cells including bacteria, parasites, fungi, and rickettsiae. The...
|
|
|
5028427 |
"Cephalosporin" compounds
β-Lactam antibiotics have the formula (Ia) or are pharmaceutically acceptable salts or pharmaceutically acceptable in vivo hydrolysable esters thereof: ##STR1## in which the group CO 2 R 1 is...
|
|
|
5015473 |
6-(substituted)methylenepenicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
Beta-lactamase inhibiting compounds of the formula ##STR1## or a pharmaceutically acceptable acid addition or carboxylate salt thereof; where n is zero, 1 or 2; X 3 is H or Br, R 1 is H, the...
|
|
|
4999195 |
Personal care products containing bioemulsifiers
Personal care products comprising bioemulsifiers, for example, those produced by Acinetobacter calcoaceticus, are provided. Use of such personal care products result in beneficial effects to skin...
|
|
|
4956374 |
Polysubstituted thiazolylpyridine carboxyamide antifungal antibiotic
Novel antifungal antibiotic compounds have the structural formula ##STR1## A preferred compound where R is 4-hydroxypentyl is denoted BU-3557B 2 . A complex of said compounds is produced by...
|
|
|
4956179 |
Antibacterial combination of penicillin and cephalosporin
An antibacterial synergistic composition consisting essentially of a mixture of a penicillin or cephalosporin derivative of the formula ##STR1## and a penicillin of the formula ##STR2## preferably...
|
|
|
4952397 |
2-quaternary heteroarylalkylthio carbapenems having an acid moiety substituent
Compounds of the formula: ##STR1## wherein ##STR2## is a quaternized, monocyclic or bicyclic heteroaryl group, substituted by an acid moiety, and their preparation and use as antibiotics are...
|
|
|
4938959 |
Insoluble medicament for a local administration in a human or animal ear
An ear powder and/or drop, containing soluble substances and an insoluble substance which will be spread of the mucous membrane and form a deposit which will act by its physical acitivity as a...
|
|
|
4919932 |
Pharmaceutical formulation for the treatment of bacterial infections
A pharmaceutical formulation having a synergistic anti-bacterial activity and comprising (a) a cephalosporin derivative or a physiologically acceptable salt or ester thereof and (b) a penem...
|
|
|
4911924 |
Induction of antibiotic hypersensitivity in tetracycline-resistance microorganisms
Microorganisms carrying tetracycline-resistant determinants are hypersensitized to Sm- and 2-DOS- aminoglycoside antibiotics by exposure to subinhibitory amounts of tetracycline inducer.
|
|
|
4898731 |
Antibiotic combinations of penicillins
An antibacterial synergistic composition consisting essentially of a mixture of a penicillin or cephalosporin derivative of the formula ##STR1## and a penicillin of the formula ##STR2## preferably...
|
|
|
4870010 |
Bioemulsified-containing personal core products for topical application to dermopathologic conditions of the skin and scalp
Personal care products comprising bioemulsifiers, for example, those produced by Acinetobacter calcoaceticus, are provided. Use of such personal care products result in beneficial effects to skin...
|
|
|
4822608 |
Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom or proteinaceous or polypeptide components thereof
Methods and compositions are described for the treatment of mammalian infections, including bacterial, viral and cancerous infections, in which hymenoptera venom or proteinaceous or polypeptide...
|